CA2212370A1 - Inhibition of angiogenesis using interleukin-12 - Google Patents

Inhibition of angiogenesis using interleukin-12

Info

Publication number: CA2212370A1
Authority: CA; Canada
Prior art keywords: angiogenesis; treatment; interleukin; mice; disease
Prior art date: 1995-02-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002212370A

Other languages

English (en)

French (fr)

Inventor

Moses Judah Folkman

Gary Arthur Truitt

Emile Eugene Voest

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Boston Childrens Hospital

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-16

Filing date

1996-02-07

Publication date

1996-08-22

1996-02-07 Application filed by Individual filed Critical Individual

1996-08-22 Publication of CA2212370A1 publication Critical patent/CA2212370A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Zoology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA002212370A 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12 Abandoned CA2212370A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38938295A	1995-02-16	1995-02-16
US08/389,382		1995-02-16

Publications (1)

Publication Number	Publication Date
CA2212370A1 true CA2212370A1 (en)	1996-08-22

Family

ID=23538033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002212370A Abandoned CA2212370A1 (en)	1995-02-16	1996-02-07	Inhibition of angiogenesis using interleukin-12

Country Status (8)

Country	Link
EP (1)	EP0809511A1 (fi)
JP (1)	JPH11500119A (fi)
AU (1)	AU4788396A (fi)
BR (1)	BR9607427A (fi)
CA (1)	CA2212370A1 (fi)
FI (1)	FI973356A0 (fi)
TR (1)	TR199700801T1 (fi)
WO (1)	WO1996025171A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998022129A1 (fr) *	1996-11-22	1998-05-28	Toray Industries, Inc.	Agent therapeutique pour maladies ophtalmiques
US5981508A (en)	1997-01-29	1999-11-09	Vanderbilt University	Facilitation of repair of neural injury with CM101/GBS toxin
US5858991A (en) *	1997-01-29	1999-01-12	Vanderbilt University	Facilitation of wound healing with CM101/GBS toxin
US6028060A (en)	1997-01-29	2000-02-22	Vanderbilt University	Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en)	1998-01-29	2003-12-30	Yeda Reaearch And Development Co., Ltd.	Facilitation of wound healing with CM101/GBS toxin
US6660258B1 (en)	1997-05-09	2003-12-09	Pharma Pacific Pty Ltd	Oromucosal cytokine compositions and uses thereof
EP0986393B1 (en) *	1997-05-27	2004-03-24	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
JP2001521906A (ja) *	1997-11-03	2001-11-13	ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー	血管新生を阻害し、癌を処置するための方法及び組成物
AU2002303168B2 (en)	2001-03-29	2005-10-06	Schering Corporation	Aryl oxime-piperazines useful as ccr5 antagonists
AU2003292838A1 (en) *	2002-12-27	2004-07-29	Kirin Beer Kabushiki Kaisha	Therapeutic agent for wet age-related macular degeneration
BRPI0408704A (pt)	2003-03-24	2006-03-07	Hoffmann La Roche	benzil-piridazinonas como inibidores de transcriptase reversa
BRPI0617720A2 (pt)	2005-10-19	2011-08-02	Hoffmann La Roche	compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém
RU2451676C2 (ru)	2006-08-16	2012-05-27	Ф.Хоффманн-Ля Рош Аг	Ненуклеозидные ингибиторы обратной транскриптазы
CA2671478C (en)	2006-12-13	2015-02-17	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
CN109789187A (zh) *	2016-07-18	2019-05-21	创新疗法医药有限公司	Il-12作为替代免疫治疗剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2106368A1 (en) *	1992-01-16	1993-07-17	Theodore E. Maione	Methods and compositions for treatment of angiogenic disease
JPH06157344A (ja) *	1992-02-07	1994-06-03	Childrens Medical Center Corp:The	血管新生阻害のための医薬製剤及び血管新生阻害方法

1996
- 1996-02-07 EP EP96904008A patent/EP0809511A1/en not_active Withdrawn
- 1996-02-07 JP JP8524631A patent/JPH11500119A/ja active Pending
- 1996-02-07 BR BR9607427A patent/BR9607427A/pt not_active Application Discontinuation
- 1996-02-07 TR TR97/00801T patent/TR199700801T1/xx unknown
- 1996-02-07 AU AU47883/96A patent/AU4788396A/en not_active Abandoned
- 1996-02-07 CA CA002212370A patent/CA2212370A1/en not_active Abandoned
- 1996-02-07 FI FI973356A patent/FI973356A0/fi unknown
- 1996-02-07 WO PCT/EP1996/000507 patent/WO1996025171A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1996025171A1 (en)	1996-08-22
BR9607427A (pt)	1998-06-23
TR199700801T1 (xx)	1998-03-21
FI973356L (fi)	1997-08-15
AU4788396A (en)	1996-09-04
MX9706188A (es)	1997-11-29
FI973356A7 (fi)	1997-08-15
JPH11500119A (ja)	1999-01-06
EP0809511A1 (en)	1997-12-03
FI973356A0 (fi)	1997-08-15

Publication	Publication Date	Title
EP0688211B1 (en)	2002-06-12	Thalidomide for inhibition of angiogenesis
USRE40360E1 (en)	2008-06-03	Methods for inhibition of angiogenesis with a composition comprising 3-hydroxythalidomide
US6228879B1 (en)	2001-05-08	Methods and compositions for inhibition of angiogenesis
US20020161023A1 (en)	2002-10-31	Method of treating diseases using 3-amino thalidomide
CA2212370A1 (en)	1996-08-22	Inhibition of angiogenesis using interleukin-12
US20120142734A1 (en)	2012-06-07	Methods for treating tumors with thalidomide
US6890906B2 (en)	2005-05-10	Method for controlling angiogenesis in animals
MXPA97006188A (en)	1998-07-03	Inhibition of angiogenesis using interleucin
US20020098176A1 (en)	2002-07-25	Inhibition of tumor growth by a nematode anticoagulant protein
HK1052865B (en)	2006-02-24	Compositions for treating cancer
CN1189102A (zh)	1998-07-29	白细胞介素－12对血管生成的抑制作用
HK1077516A (en)	2006-02-17	Methods and compositions for treating cancer

Legal Events

Date	Code	Title	Description
2001-02-07	FZDE	Discontinued